Dow up 0.58% Nasdaq up 0.47%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
 Dow up 0.58% Nasdaq up 0.47%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

Quote Results

Add Quotes

SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
04:00pm EST 23.11 -0.01 -0.04% 22.94 23.49 3,934,172 5,541,500 6.62B Sparkline Chart Chart, News, Stats, Options, Board
Feb 16 40.71 0.00 0.00% - - 0 163,131 477.54M Sparkline Chart Chart, News, Stats, Options, Board
No such ticker symbol: LNKDTry Symbol Lookup
{"s" : "exel,nile","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

Quotes delayed, except where indicated otherwise.

Recent News

day and time symbols news headline and source
Patterson Companies (PDCO) Q3 Earnings: What's in Store? Zacks08:46am EST
Blue Nile, Inc. breached its 50 day moving average in a Bullish Manner : NILE-US : February 21, 2017 at Capital Cube07:27am EST
Monday February 20, 2017
Blue Nile, Inc.: Leads amongst peers with strong fundamentals at Capital Cube04:27pm EST
Forget Alexion, Buy these 4 Biotech Stocks Instead Zacks07:52am EST
Medtronic (MDT) Q3 Earnings: Disappointment in the Cards? Zacks05:15am EST
Friday February 17, 2017
Sucampo Pharmaceuticals Set to Join S&P SmallCap 600 PR Newswire05:41pm EST
[$$] Deal Close Announcements: Feb. 13-17 at The Wall Street Journal05:12pm EST
Exelixis Announces Phase 1 Trial Results for Cabozantinib in Combination with Nivolumab with or without Ipilimumab in Refractory Metastatic Urothelial Carcinoma and Other Genitourinary Tumors Business Wire05:02pm EST
Blue Nile delists from the Nasdaq exchange Tuesday after closing $500M sale at American City Business Journals03:50pm EST
Radius Health (RDUS) Q4 Earnings: Will the Stock Disappoint? Zacks02:30pm EST
BLUE NILE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati EDGAR Online10:51am EST
Investor Group Completes Acquisition of Blue Nile GlobeNewswire10:23am EST
Easier Regulatory Environment Could Send Biotech Industry Skyrocketing in 2017: Today's Reports on Neuralstem and Exelixis Accesswire09:30am EST
Wednesday February 15, 2017
BLUE NILE INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online07:10am EST
Tuesday February 14, 2017
The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics, Exelixis and Akebia Therapeutics Zacks09:30am EST
Monday February 13, 2017
Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb at Motley Fool05:17pm EST
Forget Gilead, Buy These 5 Biotech Stocks Instead Zacks09:14am EST
Friday February 10, 2017 featured highlights: Exelixis, RPC, Unit and Fortress Transportation and Infrastructure Investors Zacks09:30am EST
Exelixis (EXEL) Shares March Higher, Can It Continue? Zacks04:10am EST
Thursday February 9, 2017
Pay's up and down for the leaders of the Seattle area's national retailers at American City Business Journals08:20pm EST
Harry Boxer’s stocks to watch: biotechnology and technology at MarketWatch12:37pm EST
Buy 4 Stocks Riding High on Superb Earnings Acceleration Zacks09:27am EST
5 Drug Stocks Poised to Beat Earnings Estimates in Q4 Zacks07:39am EST
Wednesday February 8, 2017
3 Scorching Hot Biotech Stocks -- Are They Buys? at Motley Fool04:53pm EST
Four Biotech Stocks Breaking Out at Forbes01:49pm EST